Obesity gene and use thereof
The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human obesity and diabetes predisposing gene, specifically the TBC1D1 gene, some mutant alleles of which cause susceptibility to obesity and/or diabetes. More specifically, the invention relates to germline mutations in the TBC1D1 gene and their use in the diagnosis of predisposition to obesity and diabetes. Finally, the invention relates to the screening of the TBC1D1 gene for mutations/alterations, which are useful for diagnosing the predisposition to obesity.
1. A method of determining that a human subject is at risk for obesity comprising:
assaying a sample from a human subject, and
determining that a nucleic acid from said sample comprises a cytosine to thymine alteration at the position corresponding to position 373 of SEQ ID NO: 1, wherein the presence of said cytosine to thymine alteration indentifies the subject as being at risk for developing obesity.
2. A method of analyzing a TBC1D1 gene, comprising:
assaying a sample from a human subject, and
determining that a nucleic acid from said sample comprises a cytosine to thymine alteration at the position corresponding to position 373 of SEQ ID NO: 1.
3. The method of claim 2 , wherein said human subject is diagnosed with obesity or diabetes, or at risk for obesity or diabetes.
4. The method of claim 2 , wherein said determining step comprises amplifying said nucleic acid.
5. The method of claim 2 , wherein said assaying step is conducted on genomic DNA.
6. The method of claim 2 , wherein said assaying step is conducted on cDNA.